The feasibility of replacing animal testing for assessing consumer safety: A suggested future direction

Alternatives to Laboratory Animals

Volumn 32, Issue 6, 2004, Pages 617-623

  Fentem, Julia ^a   Chamberlain, Mark ^a   Sangster, Bart ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

Alternatives; Animal testing; Clinical data; Consumer safety; Cosmetic testing; Genomics; In vitro; Proteomics; Risk assessment; Three Rs

Indexed keywords

ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ETHICS; FEASIBILITY STUDY; GENOMICS; HEALTH HAZARD; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RISK ASSESSMENT; SAFETY; TRANSCRIPTOMICS;

EID: 14644426625     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403200612     Document Type: Review

References (33)

1. EU (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European Union L66, 26-35.
2. Lisansky, S.G., Macmillan, R. & Dupuis, J., eds (1996). Alternatives to Animal Testing. Proceedings of an International Scientific Conference organised by The European Cosmetic Industry, 377pp. Newbury, Berkshire, UK: CPL Press.
3. Clark, D.G., Lisansky, S.G. & Macmillan, R., eds (1999). Alternatives to Animal Testing II. Proceedings of the Second International Scientific Conference organised by The European Cosmetic Industry, 294pp. Newbury, Berkshire, UK: CPL Press.
4. Renwick, A.G. & Lazarus, N.R. (1998). Human variability and noncancer risk assessment: an analysis of the default uncertainty value. Regulatory Toxicolology and Pharmacology 27, 3-20.
5. Renwick, A.G., Dorne, J-L.C.M. & Walton, K. (2000). An analysis of the need for an additional uncertainty factor for infants and children. Regulatory Toxicolology and Pharmacology 31, 286-296.
6. IGHRC (2003). Uncertainty Factors: Their Use in Human Health Risk Assessment by UK Government, 69pp. Leicester, UK: MRC Institute for Environment and Health. Website http://www.le.ac.uk/ieh/ pdf/er9.pdf (Accessed 3.12.04).
7. Balls, M., Goldberg, A.M., Fentem, J.H., Broadhead, C.L., Burch, R.L., Festing, M.F.W., Frazier, J.M., Hendriksen, C.F.M., Jennings, M., van der Kamp, M.D.O., Morton, D.B., Rowan, A.N., Russell, C., Russell, W.M.S., Spielmann, H., Stephens, M.L., Stokes, W.S., Straughan, D.W., Yager, J.D., Zurlo, J. & van Zutphen, B.F.M. (1995). The Three Rs: the way forward. The report and recommendations of ECVAM workshop 11. ATLA 23, 838-866.
8. Fielder, R.J., Atterwill, C.K., Anderson, D., Boobis, A.R., Botham, P., Chamberlain, M., Combes, R., Duffy, P.A., Lewis, R.W., Lumley, C.E., Kimber, I. & Newall, D.R. (1997). BTS Working Party report on in vitro toxicology. Human and Experimental Toxicology 16, S1-S40.
9. Russell, W.M.S. & Burch, R.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen.
10. EU (1986). Council Directive of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European Communities L358, 1-29.
11. Chamberlain, M. (1997). Application of QSAR, expert systems and in vitro methods. In Developments in Animal and Veterinary Sciences, Vol. 27, Animal Alternatives, Welfare and Ethics (ed. L.F.M. van Zutphen & M. Balls), pp. 723-730. Amsterdam, The Netherlands: Elsevier.
12. Eisenbrand, G., Pool-Zobel, B., Baker, V., Balls, M., Blaauboer, B.J., Boobis, A., Carere, A., Kevekordes, S., Lhuguenot, J-C., Pieters, R. & Kleiner, J. (2002). Methods of in vitro toxicology. Food and Chemical Toxicology 40, 193-236.
13. Garnis, C., Buys, T.P.H. & Lam, W.L. (2004). Genetic alteration and gene expression modulation during cancer progression. Molecular Cancer 3, 9. Website http://www.molecular-cancer.com/content/3/1/9 (Accessed 7.6.04).
14. Goldstein, A.M. (2003). Changing paradigms in dermatology: proteomics. A new approach to skin disease. Clinics in Dermatology 21, 370-374.
15. Hanash, S. (2003). Disease proteomics. Nature, London 422, 226-232.
16. Marcotte, E.R., Srivastava, L.K. & Quirion, R. (2003). cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacology and Therapeutics 100, 63-74.
17. Thomas, G. & Cann, H. (2003). Irruption of genomics in the search for disease related genes. Gut 52, Suppl. 2, 111-115.
18. Aardema, M.J. & MacGregor, J.T. (2002). Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutation Research 499, 13-25.
19. Nicholson, J.K., Connelly, J., Lindon, J.C. & Holmes, E. (2002). Metabonomics: a platform for studying drug toxicity and gene function. Nature Reviews in Drug Discovery 1, 153-161.
20. Pennie, W.D. & Kimber, I. (2002). Toxicogenomics: transcript profiling and potential application to chemical allergy. Toxicology in Vitro 16, 319-326.
21. Waters, M., Boorman, G., Bushel, P., Cunningham, M., Irwin, R., Merrick, A., Olden, K., Paules, R., Selkirk, J., Stasiewicz, S., Weis, B., van Houten, B., Walker, N. & Tennant, R. (2003). Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. Environmental Health Perspectives 111, 811-824.
22. Barratt, M.D., Castell, J.V., Chamberlain, M., Combes, R.D., Dearden, J.C., Fentem, J.H., Gerner, I., Giuliani, A., Gray, T.J.B., Livingstone, D.J., Provan, W.McL., Rutten, A.A.J.J.L., Verhaar, H.J.M. & Zbinden, P. (1995). The integrated use of alternative approaches for predicting toxic hazard. The report and recommendations of ECVAM workshop 8. ATLA 23, 410-429.
23. Basketter, D.A. (1994). Strategic hierarchical approaches to acute toxicity testing. Toxicology in Vitro 8, 855-859.
24. Robinson, M.K., Cohen, C., de Brugerolle de Fraissinette, A., Ponec, M., Whittle, E. & Fentem, J.H. (2002). Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products. Food and Chemical Toxicology 40, 573-592.
25. Worth, A.P., Fentem, J.H., Balls, M., Botham, P.A., Curren, R.D., Earl, L.K., Esdaile, D.J. & Liebsch, M. (1998). An evaluation of the proposed OECD testing strategy for skin corrosion. ATLA 26, 709-720.
26. Ideker, T., Galitski, T. & Hood, L. (2001). A new approach to decoding life: systems biology. Annual Reviews in Genomics and Human Genetics 2, 343-372.
27. Peri, S., Navarro, J.D., Amanchy, R., Kristiansen, T.Z., Jonnalagadda, C.K., et al. (2003). Development of Human Protein Reference Database as an initial platform for approaching systems biology in humans. Genome Research 13, 2363-2371.
28. You, L. (2004). Toward computational systems biology. Cellular Biochemistry and Biophysics 40, 167-184.
29. Gerberick, G.F., Ryan, C.A., Kimber, I., Dearman, R.J., Lea, L.J. & Basketter, D.A. (2000). Local lymph node assay: validation assessment for regulatory purposes. American Journal of Contact Dermatology 11, 3-18.
30. Tichias, K., Fentem, J., Basketter, D., Botham, P., Brooker, P., Bruner, L., Evans, P., Fairhurst, S., Fassold, E., Fielder, R., Gerberick, F., Harvey, P., Koëter, H., Parsons, P., Schlede, E., Shannon, D. & Spielmann, H. (1998). Progress in toxicological testing: reduction and refinement issues. Recommendations from a joint UK Government/ECVAM meeting. ATLA 26, 619-627.
31. Worth, A.P. & Balls, M., eds (2002). Alternative (non-animal) methods for chemicals testing: current status and future prospects. A report prepared by ECVAM and the ECVAM Working Group on Chemicals. ATLA 30, Suppl. 1, 125pp.
32. Fentem, J.H., Archer, G.E.B., Balls, M., Botham, P.A., Curren, R.D., Earl, L.K., Esdaile, D.J., Holzhütter, H.G. & Liebsch, M. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the Management Team. Toxicology in Vitro 12, 483-524.
33. Spielmann, H., Balls, M., Dupuis, J., Pape, W.J.W., Pechovitch, G., de Silva, O., Holzhütter, H.G., Clothier, R., Desolle, P., Gerberick, F., Liebsch, M., Lovell, W.W., Maurer, T., Pfannenbecker, U., Potthast, J.M., Csato, M., Sladowski, D., Sterling, W. & Brantom, P. (1998). EU/COLIPA "in vitro phototoxicity" validation study, results of phase II (blind trial), part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro 12, 305-327.